Atea Pharmaceuticals Inc. (AVIR)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
4. 87
+0.16
+3.2874%
$
376.13M Market Cap
- P/E Ratio
- Div Yield
225,600 Volume
-1.64 Eps
$ 4.71
Previous Close 
Want to track AVIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
AVIR Earnings Reports FAQ
What is the earnings per share (EPS) for AVIR?
The current EPS is -1.64.
What is the company's earnings growth rate?
Atea Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Atea Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Atea Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AVIR at this time, as Atea Pharmaceuticals Inc has no recent EPS data to calculate it.
